Overview

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
PF-03654764 should reduce the symptoms of allergic rhinitis. In this study patients will be exposed to pollen and their symptoms observed.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Fexofenadine
Terfenadine